A chemical agonist and the Golgi-resident lipid PI4P activate STING by inducing transmembrane helix rearrangement
While the phospholipid PI4P is implicated in STING activation, its molecular mechanism has remained elusive. Han et al. reveal that PI4P cooperates with the transmembrane agonist GNE-6468 to activate the STING immune response, highlighting its therapeutic potential for immunotherapy.